查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2005186

主動脈血管支架市場：2026-2032年全球市場預測（依動脈瘤部位、移植物類型、結構、植入機制、最終用戶、入路和材料分類）

Aortic Stent Grafts Market by Aneurysm Location, Graft Type, Configuration, Deployment Mechanism, End User, Access Route, Material - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，主動脈血管支架市場價值將達到 11.3 億美元，到 2026 年將成長至 12.1 億美元，到 2032 年將達到 17.8 億美元，複合年成長率為 6.62%。

主要市場統計數據
基準年 2025 11.3億美元
預計年份：2026年 12.1億美元
預測年份 2032 17.8億美元
複合年成長率 (%) 6.62%

對當前主動脈血管支架生態系統以及醫療技術領導者和臨床相關人員應指南的策略挑戰進行權威概述。

主動脈血管支架領域正處於一個關鍵的十字路口，醫療設備技術的進步、臨床實踐模式的改變以及對成本和治療結果日益嚴格的監測交織在一起。臨床醫生越來越傾向於採用微創血管內治療來治療各種主動脈疾病，而器械開發商則致力於平台創新，以提高支架的貼合度、閉塞效果和分支血管的保護。同時，醫院和門診手術中心正在重新審視其採購系統，以在手術數量和永續的臨床療效之間取得平衡。

主動脈治療領域正在發生變革性變化，重塑臨床實務、產品設計和經營模式。

主動脈血管支架領域正受到多種趨勢的共同影響，這些趨勢正在改變器械的設計、評估和應用方式。首先，器械結構正朝著更貼合解剖結構的方向發展，採用更複雜的分支和開窗結構的解決方案能夠治療以往被認為無法手術的解剖結構。同時，輸送系統的進步也促進了這一趨勢，提高了操作便利性並縮小了器械體積，從而擴大了目標患者群體的手術適應症範圍。此外，長期臨床數據和真實世界證據的積累，也增強了血管內修復提案相對於開放性手術某些類型動脈瘤的價值，從而推動了一種優先選擇微創治療方案的治療策略，前提是治療效果和手術入路允許。

近期美國關稅措施對臨床供應鏈和製造商策略的累積影響。

近期針對醫療設備零件和成品的關稅措施為器械製造商和醫療系統帶來了新的成本和營運挑戰。由於關稅導致投入成本增加，製造商正在重新思考籌資策略，將生產重心轉移到貿易環境更穩定的地區，或透過供應商多元化來規避關稅波動風險。這種調整影響了前置作業時間、庫存水準和供應商認證進度，對短期供應連續性構成壓力，並要求採購團隊採取積極主動的措施。

基於解剖結構、器材、手術和最終用戶細分的關鍵細分見解，以製定臨床和商業策略。

主動脈血管支架市場根據幾個具有重要臨床意義的因素進行細分，這些因素影響產品需求和市場進入策略。動脈瘤的位置是主要決定因素，可分為腹部主動脈血管瘤主動脈瘤、胸主動脈瘤和腹部主動脈血管瘤。每種解剖亞型在入路、封鎖和分支血管保護方面都面臨不同的挑戰。在這些類別中，臨床緊急程度區分了規劃手術和急診手術，從而影響器械庫存需求、商店供應以及快速部署培訓的需求。

影響全球主要市場差異化商業化和臨床導入策略的區域趨勢

區域趨勢影響著科技的採納、監管和採購，因此需要製定在地化的策略。在美洲，臨床證據與報銷方案的一致性備受重視，醫院和病患量大的醫療中心往往是複雜分支和開放式診療系統的早期採用者。相較之下，歐洲、中東和非洲（EMEA）地區的技術採納率參差不齊，這主要是由於各國採購通訊協定、報銷環境的波動以及醫院基礎設施的巨大差異。這些因素共同導致部分地區的技術採納較為先進，而其他地區則因成本和准入限制而發展受限。

深入分析競爭格局，重點放在醫療設備製造商與生態系統合作夥伴之間的策略行動、能力差距和合作機會。

主要企業繼續透過結合技術差異化、臨床證據和服務水準保證來展開競爭。產品藍圖日益強調模組化和解剖結構客製化，以應對複雜的解剖結構，而其他製造商則專注於低調的輸送系統和簡化的部署，以適應頻繁的選擇性手術項目。策略性舉措包括有針對性的收購，以彌補分支和開窗技術領域的能力缺口，以及旨在加速專業解決方案上市的授權和共同開發契約。

產業領導者可以實施的實用建議，以增強韌性、加速推廣應用並最大限度地發揮臨床影響。

製造商應優先考慮模組化產品平台，以提高生產效率和庫存管理水平，同時應對各種不同的解剖結構挑戰。投資於產生全面的臨床證據，包括前瞻性註冊研究和可操作的真實世界研究，可以增強對醫院和保險公司的價值提案，並降低產品推廣的門檻。在營運方面，關鍵零件供應商多元化，並探索本地製造和契約製造夥伴關係，可以提高對本地需求的應對力，同時降低關稅和物流風險。

用於評估主動脈血管支架臨床、商業性和監管方面的調查方法和證據整合方法。

本分析採用混合研究設計，整合了原始質性資料和全面的二手資訊。原始研究部分，我們對臨床醫生、醫院採購經理和醫療設備研發專家進行了結構化訪談，以了解臨床實踐模式、器材選擇標準和採購考量。我們將這些定性研究結果與二手資訊進行交叉比對，包括同行評審的臨床文獻、已發布的監管附加檔、臨床試驗註冊資訊和醫療指南，以檢驗技術聲明和臨床性能說明。

結論整合了對臨床、商業和營運領域相關人員的策略意義。

主動脈血管支架領域正邁入一個新階段，在這個階段，技術複雜性、對實證醫學的需求以及供應鏈的韌性三者將共同決定競爭優勢。成功的關鍵在於提供既能滿足日益複雜的解剖學要求，又能同時展現臨床療效和成本效益的器材。那些將研發進展與嚴謹的實證醫學體系和穩健的營運策略結合的機構，將更有能力滿足臨床醫師的期望和採購需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：按動脈瘤部位分類的主動脈血管支架市場

  • 腹部主動脈血管瘤
  • 胸主動脈瘤
  • 胸腹腹部主動脈血管瘤

第9章：主動脈血管支架市場（依移植物類型分類）

  • 分支支架血管支架
  • 開窗型血管支架
  • 標準血管支架

第10章：主動脈血管支架市場：依組成

  • 主動脈 - 單側髂動脈
  • 分支類型
  • 袖口

第11章 主動脈血管支架市場（依植入方法分類）

  • 球囊擴張型
  • 自膨脹

第12章 主動脈血管支架市場：依最終用戶分類

  • 門診手術中心
  • 醫院

第13章：主動脈血管支架市場進入路管道分類）

  • 髂骨
  • 經股動脈

第14章 主動脈血管支架市場：依材料分類

  • 膨體聚四氟乙烯
  • 聚酯纖維

第15章 主動脈血管支架市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 主動脈血管支架市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 主動脈血管支架市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國主動脈血管支架市場

第19章：中國主動脈血管支架市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Aortec Medical Technology Co., Ltd
  • Aptus Endosystems, Inc.
  • Artivion, Inc.
  • Becton, Dickinson and Company
  • Bentley InnoMed GmbH
  • Bolton Medical Inc.
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • CryoLife, Inc.
  • Endologix, Inc.
  • Endospan Ltd
  • JOTEC GmbH
  • LifeTech Scientific Co., Ltd
  • Lombard Medical Ltd
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • WL Gore & Associates, Inc.
Product Code: MRR-B168537782D2

The Aortic Stent Grafts Market was valued at USD 1.13 billion in 2025 and is projected to grow to USD 1.21 billion in 2026, with a CAGR of 6.62%, reaching USD 1.78 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.13 billion
Estimated Year [2026] USD 1.21 billion
Forecast Year [2032] USD 1.78 billion
CAGR (%) 6.62%

An authoritative orientation to the current aortic stent graft ecosystem and the strategic imperatives that should guide medtech leaders and clinical stakeholders

The aortic stent graft sector occupies a critical juncture at the intersection of advancing device technology, shifting clinical practice patterns, and heightened scrutiny on cost and outcomes. Clinicians increasingly favor minimally invasive endovascular therapies for a broadening set of aortic pathologies, while device developers pursue platform innovations that improve conformability, seal, and branch vessel preservation. At the same time, hospitals and ambulatory surgical centers are recalibrating procurement frameworks to balance procedural throughput with durable clinical results.

This introduction frames the principal forces shaping product development, clinical adoption, and commercial strategy. It synthesizes recent regulatory milestones, emergent clinical evidence, and supply chain considerations that now inform go-to-market decisions. Readers will gain an actionable orientation to the priority challenges and opportunities facing manufacturers, providers, and payers, enabling clearer alignment of R&D, commercial, and policy objectives as they plan for the short and medium term.

In the sections that follow, the report distills structural shifts across technology, reimbursement environments, and geography, then translates those observations into segmentation, regional, and competitive insights designed to inform investment and product strategy decisions.

Transformative shifts reshaping clinical practice, product design, and commercial models in aortic therapeutics

The landscape of aortic stent grafts is being reshaped by several convergent trends that alter how devices are designed, evaluated, and adopted. First, device architectures are moving toward greater anatomic customization, with more complex branched and fenestrated solutions enabling treatment of previously inoperable anatomies. This trend is complemented by advances in delivery systems that improve navigability and lower profile, which together expand the procedural candidacy across patient cohorts. Simultaneously, the accumulation of long-term clinical data and real-world evidence has strengthened the value proposition of endovascular repair versus open surgery for selected aneurysm types, prompting care pathways to prioritize minimally invasive options where outcomes and access permit.

On the commercial front, procurement strategies are becoming more value-driven; hospitals and ambulatory surgical centers increasingly require evidence of cost-effectiveness, device longevity, and post-market surveillance commitments. This has elevated the importance of lifecycle data and post-approval studies, encouraging manufacturers to invest in registries and partnerships with clinical centers. Supply chain resilience has also become a strategic priority, with manufacturers reassessing supplier concentration, dual sourcing critical components, and exploring regional manufacturing footprints to mitigate disruption risks. Collectively, these shifts are driving a more integrated approach to innovation, where clinical evidence generation, manufacturing robustness, and commercial alignment are no longer sequential priorities but simultaneous imperatives.

Cumulative impact of recent United States tariff actions on clinical supply chains and manufacturer strategies

Recent tariff actions affecting medical device components and finished products have introduced new cost and operational dynamics for device manufacturers and health systems. Tariff-induced increases in input costs have prompted manufacturers to reassess sourcing strategies, shifting production emphasis toward regions with more predictable trade terms or to diversify suppliers to hedge against tariff volatility. This reconfiguration has implications for lead times, inventory carrying, and supplier qualification timelines, creating near-term pressures on supply continuity that require proactive mitigation by procurement teams.

Clinicians and hospital administrators have felt the downstream effects through tighter negotiation cycles and heightened scrutiny of total procedure costs. In response, some manufacturers have pursued margin protection strategies that include selective regional pricing adjustments, renegotiated supplier contracts, and targeted product bundling that rationalizes inventory. At the same time, providers have accelerated efforts to validate suppliers' long-term commitments to service levels and warranty performance, since supply disruptions can threaten elective procedure scheduling.

Regulatory and compliance teams are adapting to tariff-related documentation and classification challenges, which can slow customs clearance and add administrative overhead. To manage these effects, forward-looking organizations are investing in scenario planning, flexible manufacturing arrangements, and closer collaboration between commercial strategy and operations to preserve clinical access while navigating the shifting trade landscape.

Key segmentation insights drawing on anatomic, device, procedural, and end-user distinctions that structure clinical and commercial strategy

The market for aortic stent grafts fragments along multiple clinically meaningful dimensions that shape product requirements and go-to-market strategies. Aneurysm location is a primary determinant, separating abdominal aortic aneurysm from thoracic aortic aneurysm and thoracoabdominal aortic aneurysm, with each anatomic subset presenting distinct access, sealing, and branch preservation challenges. Within these categories, the clinical urgency differentiates elective repair cases from emergency repair scenarios, influencing device inventory needs, on-shelf availability, and training imperatives for rapid deployment.

Graft type drives technical differentiation and clinical value, with branched stent grafts and fenestrated stent grafts tailored to complex, branch-involving anatomies, while standard stent grafts address more straightforward profiles and often prioritize ease of delivery. Configuration nuances such as aorto-uni-iliac, bifurcated, and cuff designs determine fixation mechanics and compatibility with adjunctive devices, shaping both procedure planning and post-procedural surveillance. Deployment mechanics separate balloon expandable systems from self expanding platforms, each conferring trade-offs in radial force, conformability, and delivery sheath size that affect case selection and operator preference.

End-user setting exerts a profound influence on procurement cycles and support models, as ambulatory surgical centers prioritize throughput and device simplicity, whereas hospitals manage a broader mix of elective and emergency volumes requiring diverse inventory. Access route choices, notably iliac versus transfemoral approaches, steer product profile requirements and anatomical constraints. Finally, material selection such as expanded polytetrafluoroethylene versus polyester fabrics impacts long-term durability, thrombogenicity considerations, and regulatory dossier composition. Taken together, these segmentation axes demand that manufacturers align portfolio breadth with clinical training programs and targeted evidence to support adoption across heterogeneous care settings.

Regional dynamics that inform differentiated commercialization and clinical adoption approaches across major global markets

Regional dynamics shape how technologies are adopted, regulated, and purchased, requiring tailored strategies for each geography. The Americas market exhibits a strong emphasis on clinical evidence and reimbursement alignment, with hospitals and high-volume centers often acting as early adopters for complex branched and fenestrated systems. In contrast, Europe, Middle East & Africa displays heterogeneous adoption rates driven by national procurement protocols, variable reimbursement environments, and widely differing hospital infrastructures, which together create both pockets of advanced uptake and regions where cost and access constraints limit penetration.

Asia-Pacific markets present a diverse set of opportunities, where rapid hospital expansion and increasing investment in minimally invasive surgery are driving demand for a wider array of device configurations, yet local regulatory pathways and preferences for cost-competitive solutions shape purchasing choices. Across all regions, logistical considerations such as customs processes, regional distributor capabilities, and local training capacity materially influence time-to-adoption. Consequently, manufacturers that combine robust clinical support, adaptable pricing models, and regional supply chain resilience are better positioned to capture sustained uptake across these varied markets.

Competitive landscape insights highlighting strategic behaviors, capability gaps, and partnership opportunities among device manufacturers and ecosystem partners

Leading companies continue to compete on a combination of technical differentiation, clinical evidence, and service-level guarantees. Product roadmaps increasingly emphasize modularity and anatomical customization to capture complex anatomies, while other manufacturers concentrate on low-profile delivery systems and simplified deployment to address high-volume elective programs. Strategic behaviors also include targeted acquisitions to fill capability gaps in branched or fenestrated technologies, as well as licensing arrangements and co-development agreements designed to accelerate time to market for specialized solutions.

Emerging entrants often leverage narrow innovation niches-improved fixation mechanisms, novel fabric technologies, or advanced imaging integration-to gain clinical footholds, but scaling those innovations requires robust clinical partnerships and distribution capabilities. Established players retain advantages in global regulatory experience, manufacturing scale, and installed clinical support networks, yet they face pressure to demonstrate post-market outcomes and cost-effectiveness. There is growing evidence of collaborative models where manufacturers, clinical centers, and payers co-design registries and long-term follow-up studies to validate real-world performance and support reimbursement discussions. Overall, the competitive dynamic rewards organizations that pair technical differentiation with operational excellence and credible long-term evidence commitments.

Actionable recommendations that industry leaders can implement to enhance resilience, accelerate adoption, and maximize clinical impact

Manufacturers should prioritize modular product platforms that can address a spectrum of anatomic challenges while enabling manufacturing efficiency and inventory rationalization. Investing in comprehensive clinical evidence generation, including prospective registries and pragmatic real-world studies, will strengthen value propositions with hospitals and payers and reduce barriers to adoption. Operationally, diversifying critical component suppliers and exploring regional manufacturing or contract manufacturing partnerships can reduce tariff and logistics exposure while improving responsiveness to local demand.

Commercial teams should design differentiated go-to-market approaches for hospitals versus ambulatory surgical centers, aligning training, inventory models, and post-procedural support accordingly. Strategic collaborations with high-volume clinical centers to build centers of excellence and targeted training curricula can shorten adoption curves. Finally, engaging early with health economics experts and payer stakeholders to build clear reimbursement narratives will be essential for securing formulary placement and unit uptake, particularly for higher-cost branched and fenestrated solutions that deliver demonstrable downstream value.

Research methodology and evidence synthesis approach used to evaluate clinical, commercial, and regulatory dimensions of aortic stent grafts

The analysis integrates a mixed-methods research design that synthesizes primary qualitative inputs with comprehensive secondary evidence. Primary engagement included structured interviews with clinicians, hospital procurement leaders, and device development experts to capture practice patterns, device preferences, and procurement sensitivities. These qualitative insights were triangulated with secondary sources including peer-reviewed clinical literature, public regulatory filings, device labeling, clinical trial registries, and institutional guidelines to validate technical claims and clinical performance narratives.

Data synthesis emphasized cross-validation across independent sources and the use of scenario analysis to assess the robustness of strategic conclusions under varying operational assumptions. Where available, post-market surveillance summaries and registry data were used to contextualize durability and safety profiles. The methodology also incorporated rigorous segmentation mapping to align device features with clinical use-cases and buyer archetypes. Throughout, the approach aimed to balance depth of clinical insight with practical commercial implications to deliver a usable framework for decision-making.

Conclusion synthesizing strategic implications for stakeholders across clinical, commercial, and operational domains

The aortic stent graft sector is advancing into a phase where technical complexity, evidence demands, and supply chain resilience jointly define competitive advantage. Success will hinge on the ability to deliver devices that match increasingly sophisticated anatomic requirements while simultaneously demonstrating real-world outcomes and cost-effectiveness. Organizations that integrate R&D advances with rigorous evidence programs and resilient operational strategies will be best positioned to meet clinician expectations and procurement demands.

Looking forward, the interplay between evolving clinical indications, tariff and trade pressures, and regional adoption heterogeneity will create both challenges and opportunities. Firms that adopt a disciplined approach to segmentation, prioritize high-impact clinical partnerships, and build flexible manufacturing and distribution models will be able to accelerate adoption across diverse care settings. The actionable recommendations provided here are intended to guide leaders in aligning product portfolios, evidence generation, and operational capabilities to capture the long-term value potential inherent in modern aortic therapies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Aortic Stent Grafts Market, by Aneurysm Location

  • 8.1. Abdominal Aortic Aneurysm
  • 8.2. Thoracic Aortic Aneurysm
  • 8.3. Thoracoabdominal Aortic Aneurysm

9. Aortic Stent Grafts Market, by Graft Type

  • 9.1. Branched Stent Graft
  • 9.2. Fenestrated Stent Graft
  • 9.3. Standard Stent Graft

10. Aortic Stent Grafts Market, by Configuration

  • 10.1. Aorto-Uni-Iliac
  • 10.2. Bifurcated
  • 10.3. Cuff

11. Aortic Stent Grafts Market, by Deployment Mechanism

  • 11.1. Balloon Expandable
  • 11.2. Self Expanding

12. Aortic Stent Grafts Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals

13. Aortic Stent Grafts Market, by Access Route

  • 13.1. Iliac
  • 13.2. Transfemoral

14. Aortic Stent Grafts Market, by Material

  • 14.1. Expanded Polytetrafluoroethylene
  • 14.2. Polyester

15. Aortic Stent Grafts Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Aortic Stent Grafts Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Aortic Stent Grafts Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Aortic Stent Grafts Market

19. China Aortic Stent Grafts Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Abbott Laboratories
  • 20.6. Aortec Medical Technology Co., Ltd
  • 20.7. Aptus Endosystems, Inc.
  • 20.8. Artivion, Inc.
  • 20.9. Becton, Dickinson and Company
  • 20.10. Bentley InnoMed GmbH
  • 20.11. Bolton Medical Inc.
  • 20.12. Cardinal Health, Inc.
  • 20.13. Cook Medical LLC
  • 20.14. CryoLife, Inc.
  • 20.15. Endologix, Inc.
  • 20.16. Endospan Ltd
  • 20.17. JOTEC GmbH
  • 20.18. LifeTech Scientific Co., Ltd
  • 20.19. Lombard Medical Ltd
  • 20.20. Medtronic plc
  • 20.21. Merit Medical Systems, Inc.
  • 20.22. MicroPort Scientific Corporation
  • 20.23. Terumo Corporation
  • 20.24. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AORTIC STENT GRAFTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL AORTIC STENT GRAFTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY THORACOABDOMINAL AORTIC ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY THORACOABDOMINAL AORTIC ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY THORACOABDOMINAL AORTIC ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY BRANCHED STENT GRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY BRANCHED STENT GRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY BRANCHED STENT GRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY FENESTRATED STENT GRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY FENESTRATED STENT GRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY FENESTRATED STENT GRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY STANDARD STENT GRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY STANDARD STENT GRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY STANDARD STENT GRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY AORTO-UNI-ILIAC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY AORTO-UNI-ILIAC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY AORTO-UNI-ILIAC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY BIFURCATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY BIFURCATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY BIFURCATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY CUFF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY CUFF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY CUFF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY BALLOON EXPANDABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY BALLOON EXPANDABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY BALLOON EXPANDABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY SELF EXPANDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY SELF EXPANDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY SELF EXPANDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ILIAC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ILIAC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ILIAC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY TRANSFEMORAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY TRANSFEMORAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY TRANSFEMORAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY EXPANDED POLYTETRAFLUOROETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY EXPANDED POLYTETRAFLUOROETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY EXPANDED POLYTETRAFLUOROETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS AORTIC STENT GRAFTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 134. GCC AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GCC AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 136. GCC AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. GCC AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 138. GCC AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 139. GCC AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. GCC AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 141. GCC AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 158. G7 AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. G7 AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 160. G7 AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. G7 AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 162. G7 AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 163. G7 AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. G7 AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 165. G7 AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 166. NATO AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. NATO AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 168. NATO AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. NATO AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 170. NATO AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 171. NATO AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. NATO AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 173. NATO AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)